Shandong Buchang Pharmaceuticals Co.,Ltd. Posted 1.7 Billion Yuan Net Loss in 2022

Shandong Buchang Pharmaceuticals Co.,Ltd. (山东步长制药股份有限公司) (603858.SH) reported a net loss of 1.7 billion yuan in 2022, reversing a net profit of 1.2 billion yuan for the previous year.

Meanwhile, the company posted 15 billion yuan in revenue, down 5.1% year-on-year.

At the end of the reporting period, it had 22 billion yuan in total assets and 9.7 billion yuan in total liabilities, with a liability-to-asset ratio of 44.1%.